Economic benefits of safety-engineered sharp devices in Belgium - a budget impact model

Table 1 Estimated annual number, cost and NSI rate associated with procedures in Belgium

Procedure class	Annual number of devices per bed (estimated)	Average cost of conventional devices (€)	Average cost of SEDs (€)	NSI rate using conventional devices(per 10⁵procedures)	NSI rate using SEDs (per 10⁵procedures)[15]
Injection	553	0.014	0.046	10.8 [15]	1.5
Infusion therapy	120	0.400	0.600	26.0 [15]	8.8
Diabetes insulin administration	50 [8]	0.095	0.315	23.5 [18]	3.3**
Blood collection	193	0.170	0.270	23.4* [15]	7.0***

*It was assumed that arterial and venous blood collection procedures result in the same percentage of NSIs.
**It was assumed that the reduction in NSIs after the introduction of 2^nd generation safety-engineered diabetes care devices is the same as that achieved by injection SEDs.
***It was assumed that safety-engineered arterial and venous blood collection devices achieve the same reduction.

ISSN: 1472-6963